News & Press: Latest News

MDMA Response to President Trump's Address to Congress

Wednesday, March 1, 2017  
Share |

MDMA Response to President Trump’s

Address to Congress

WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA) issued the following statement regarding President Trump’s address to a joint session of Congress:

“MDMA applauds President Trump's call for a new generation of cures and therapies to improve patient care, and medical technology entrepreneurs stand ready to boost innovation and job creation.

“Medical technology innovators have a proud tradition of creating good paying jobs, but they need the proper policies in place to continue doing so.  Fully repealing the medical device tax, establishing a more transparent and predictable regulatory process, lowering corporate taxes and properly reimbursing medical technologies would create an environment that allows this proud American industry to thrive. 

“Policy makers are well aware of the challenges confronting our health care delivery system and our economy, and it is critical that they enact legislation that will that create a framework to solve them.  Med tech innovators are at the forefront of developing new cures and therapies to address chronic conditions and rare diseases, and we must support this important work.

“MDMA and the medical technology industry look forward to working with President Trump, Congress and all stakeholders to achieve our common goals of strengthening the economy, patient care and our entire health care ecosystem.”